MAPT and Alzheimer disease: In STZ-induced rats which displayed AD features, melatonin was effective in decreasing both Aβ formation and tau proteins hyperphosphorylation in hippocampus, as well as reducing the phosphorylation of IRS1 and restoring the phosphorylation of glycogen synthase kinase 3β (GSK3β) 104.